Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
agonist, armed, begun, composed, count, cycle, Gaza, innovative, Israel, larger, leasehold, Nordisk, Novo, Ozempic, peptide, receptor, Senate, slight, stopped, study, uncollectible
Removed:
collectible, conformed, duration, Europe, fee, fewer, manner, missed
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view